Valneva SE (VALN) Total Liabilities (2020 - 2026)

Valneva SE (VALN) posted quarterly Total Liabilities of $336.1 million for Q1 2026, down 3.8% year-on-year from $349.3 million in Q1 2025, and up 0.9% on a QoQ basis from $333.0 million in Q4 2025.

Valneva SE (VALN) Total Liabilities (2020 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Total Liabilities for 7 consecutive years, with $336.1 million the latest figure, recorded in Q1 2026.

  • Quarterly Total Liabilities fell 3.8% year-over-year to $336.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $336.1 million (down 3.8% YoY) and the FY2025 annual result came in at $333.0 million, down 8.19% from the prior year.
  • Total Liabilities climbed to $336.1 million in Q1 2026 per VALN's latest filing, from $333.0 million in the prior quarter.
  • Over the last five years, Total Liabilities for VALN reached as high as $719.0 million in Q2 2022 and fell as low as $325.7 million in Q2 2025.
  • A 5-year average of $424.3 million and a median of $362.8 million in 2024 frame the typical range for Total Liabilities.
  • Annual changes were most pronounced in 2023 — Total Liabilities tumbled 44.31% — and 2025, when it slipped 0.47%.
  • Year by year, Total Liabilities stood at $456.9 million in 2022, then decreased by 17.37% to $377.6 million in 2023, then dropped by 3.93% to $362.8 million in 2024, then fell by 8.19% to $333.0 million in 2025, then grew by 0.9% to $336.1 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $336.1 million, $333.0 million, and $338.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 60.46 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 177.22 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 3.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 7.33 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 7.12 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 9.45 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 15.48 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.62 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 753.82 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn 336.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 336.05 Mn
Dec 31, 2025 333.04 Mn
Sep 30, 2025 338.83 Mn
Jun 30, 2025 325.67 Mn
Mar 31, 2025 349.34 Mn
Dec 31, 2024 362.76 Mn
Sep 30, 2024 340.41 Mn
Jun 30, 2024 341.72 Mn
Mar 31, 2024 356.86 Mn
Dec 31, 2023 377.59 Mn
Sep 30, 2023 413.10 Mn
Jun 30, 2023 400.41 Mn
Mar 31, 2023 438.36 Mn
Dec 31, 2022 456.94 Mn
Sep 30, 2022 606.64 Mn
Jun 30, 2022 719.02 Mn
Mar 31, 2022 716.12 Mn
Dec 31, 2021 736.00 Mn
Dec 31, 2020 423.03 Mn